DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
265	脂肪萎縮症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02684591 (ClinicalTrials.gov)	January 2016	15/1/2016	Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy	Aramchol Versus Placebo in the Treatment of HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy: A Randomized, Double-blinded, Allocation-concealed, Placebo-controlled Clinical Trial	Nonalcoholic Fatty Liver Disease;HIV	Drug: Aramchol;Drug: Placebo	University of California, San Diego	NULL	Completed	18 Years	N/A	All	50	Phase 2	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02684591
(ClinicalTrials.gov)

January 2016

15/1/2016

Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy

Aramchol Versus Placebo in the Treatment of HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy: A Randomized, Double-blinded, Allocation-concealed, Placebo-controlled Clinical Trial

Nonalcoholic Fatty Liver Disease;HIV

Drug: Aramchol;Drug: Placebo

University of California, San Diego

NULL

Completed

18 Years

N/A

All

Phase 2

United States